2018
DOI: 10.3233/blc-180163
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Adjuvant Radiation Therapy in Locally Advanced Bladder Cancer

Abstract: Background:The standard of care for locally advanced bladder cancer (LABC) is neoadjuvant chemotherapy followed by cystectomy. However, the role of adjuvant therapy for locally advanced bladder cancer is unclear.Objective:The purpose of this study was to evaluate the outcomes of adjuvant radiation therapy (RT) for patients with LABC, and to determine which risk factors best predict for patients who may best benefit from adjuvant RT.Methods:The National Cancer Data Base (NCDB) was queried (2004– 2013) for patie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
20
0
2

Year Published

2019
2019
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(22 citation statements)
references
References 26 publications
0
20
0
2
Order By: Relevance
“…Patients with urothelial carcinoma with squamous and/or glandular differentiation are more likely to have pT3-T4 tumours (70% vs 38%, p < 0.0001) and pN+ disease (20% vs 15%, p = 0.05) than those with pure urothelial carcinoma, confirming the observation that they are more likely to die of local than of distant metastatic disease [23]. This would provide a strong argument to consider improving local control by adjuvant radiotherapy, especially in cases of positive margins at areas amenable for radiotherapy [24,25].…”
Section: The Role Of Adjuvant Radiotherapy For the Treatment Of Mibc mentioning
confidence: 64%
“…Patients with urothelial carcinoma with squamous and/or glandular differentiation are more likely to have pT3-T4 tumours (70% vs 38%, p < 0.0001) and pN+ disease (20% vs 15%, p = 0.05) than those with pure urothelial carcinoma, confirming the observation that they are more likely to die of local than of distant metastatic disease [23]. This would provide a strong argument to consider improving local control by adjuvant radiotherapy, especially in cases of positive margins at areas amenable for radiotherapy [24,25].…”
Section: The Role Of Adjuvant Radiotherapy For the Treatment Of Mibc mentioning
confidence: 64%
“…Patients with urothelial carcinoma with squamous and/or glandular differentiation are more likely to have pT3-T4 tumours (70% versus 38%, P < 0.0001) and pNþ disease (20% versus 15%, P ¼ 0.05) than those with pure urothelial carcinoma, confirming the observation that they are more likely to die of local than distant metastatic disease [23]. This would provide a strong argument to consider improving local control by adjuvant radiotherapy especially in cases of positive margins at areas amenable for radiotherapy [24,25].…”
mentioning
confidence: 65%
“…The NCDB is a national hospital‐based cancer registry that is cosponsored by the American College of Surgeons (ACoS) and the American Cancer Society. It houses data from more than 1500 hospitals with ACoS‐accredited cancer‐treatment programs, accounting for almost 70% of all newly diagnosed cancer cases in the United States . A case list of patients with biopsy‐proven IMPC diagnosed between January 2007 and December 2012 was retrieved from the NCDB.…”
Section: Methodsmentioning
confidence: 99%